Forte Biosciences, Inc.
FBRX
$18.31
-$0.78-4.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 93.41M | 106.14M | 45.86M | 58.37M | 16.36M |
| Total Receivables | 527.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.00M | 884.00K | 853.00K | 2.65M | 1.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 471.00K | 588.00K | 449.00K | 336.00K | 274.00K |
| Total Current Assets | 95.41M | 107.62M | 47.16M | 61.35M | 17.67M |
|
|
|||||
| Total Current Assets | 95.41M | 107.62M | 47.16M | 61.35M | 17.67M |
| Net Property, Plant & Equipment | 148.00K | 110.00K | 125.00K | 77.00K | 86.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.53M | 57.00K | 176.00K | 138.00K | 192.00K |
| Total Assets | 97.09M | 107.78M | 47.46M | 61.56M | 17.95M |
|
|
|||||
| Total Accounts Payable | 5.49M | 5.30M | 5.02M | 4.88M | 5.16M |
| Total Accrued Expenses | 7.50M | 3.87M | 4.01M | 4.20M | 3.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.99M | 9.17M | 9.03M | 9.08M | 8.58M |
|
|
|||||
| Total Current Liabilities | 12.99M | 9.17M | 9.03M | 9.08M | 8.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.99M | 9.17M | 9.03M | 9.08M | 8.58M |
|
|
|||||
| Common Stock & APIC | 282.69M | 279.52M | 208.08M | 206.47M | 156.21M |
| Retained Earnings | -198.59M | -180.90M | -169.65M | -154.00M | -146.84M |
| Treasury Stock & Other | -6.00K | -- | -- | 11.00K | 1.00K |
| Total Common Equity | 84.10M | 98.61M | 38.43M | 52.48M | 9.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 84.10M | 98.61M | 38.43M | 52.48M | 9.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 84.10M | 98.61M | 38.43M | 52.48M | 9.37M |
|
|
|||||